International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.7951153
Original Article
To Study the Incidence of Recurrence Rate of Carcinoma Breast in Patient Visiting Department of Surgery at Tertiary Care Hospital and Treated with Available Facilities and Modalities at Gajra Raja Medical College, Gwalior, Madhya Pradesh
 ,
 ,
 ,
Published
May 19, 2023
Abstract
Introduction: Breast cancer is the most prevalent site-specific cancer in women and the leading cause of cancer-related mortality among women aged 20 to 59. When normal cells in the lobules, ducts, or other breast tissue become damaged and proliferate uncontrollably, breast cancer develops. The aberrant cells multiply and collect rapidly, forming a mass known as a tumor. Objective: study to assess the incidence of recurrence rate of carcinoma breast in patient visiting Department of Surgery and treated with available facilities and modalities at Gajra Raja Medical College, Gwalior. Methodology: A Retrospective observational study was conducted in the patients visiting surgery department in GRMC, GWALIOR Districts of MP. Total 50 patients diagnosed with clinical palpable breast lump with FNAC status positive who were admitted in Surgical Ward, Department of General Surgery, G.R.M.C., Gwalior by using SPSS 25. Result: Recurrence of breast carcinoma was reported by 34% patients only. Whereas 66% patients were reported with no recurrence. Majority of the patients were aged between 45-49 years, i.e. [08(47.06%)], followed by 50-54 years [07(41.18%)] . it was found that out of the total enrolled patients maximum i.e. 46% were detected for Ductal cell carcinoma in situ, followed by 30% patients for Invasive ductal carcinoma and so on. Conclusion: Findings of our study indicate that, it was observed that despite a higher incidence of recurrence it was reported only in 34% of total enrolled and successfully treated patients. This indicates that breast carcinoma can be managed and treated successfully.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
1631 Views
407 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved